DB03861 - (2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium
| Identification | |
|---|---|
| Name | (2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium |
| Accession Number | DB03861 (EXPT01846) |
| Type | small molecule |
| Description | Not Available |
| Structure |
|
| Categories (*) | |
| Molecular Weight | 204.2236 |
| Groups | experimental |
| Monoisotopic Weight | 204.11100701 |
| Pharmacology | |
| Indication | Not Available |
| Mechanism of action | Not Available |
| Absorption | Not Available |
| Protein binding | Not Available |
| Biotransformation | Not Available |
| Route of elimination | Not Available |
| Toxicity | Not Available |
| Affected organisms | Not Available |
| Interactions | |
| Drug Interactions | Not Available |
| Food Interactions | Not Available |
Targets
| Beta-hexosaminidase beta chain | |
|---|---|
| Name | Beta-hexosaminidase beta chain |
| Gene Name | HEXB |
| Pharmacological action | unknown |
| Actions | Not Available |
| References | |
| DTHybrid score | 1.312 |
| Calcium-activated potassium channel subunit beta 2 | |
| Name | Calcium-activated potassium channel subunit beta 2 |
| Gene Name | KCNMB2 |
| Pharmacological action | unknown |
| Actions | Not Available |
| References | Not Available |
| DTHybrid score | 0.6888 |